A prospective study to assess the pharmacotherapeutic management of chronic diabetic foot ulcers in a tertiary care hospital
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20262778Keywords:
Diabetic foot ulcer, Drug utilization, Prescriptions predictors, Prospective studiesAbstract
Background: Chronic diabetic foot ulcers (DFUs) are a major cause of morbidity, prolonged hospitalization, and non-traumatic lower-limb amputations in patients with diabetes mellitus. Effective management requires rational pharmacotherapy, appropriate antimicrobial use, and objective wound assessment. This study evaluated pharmacotherapeutic management, drug utilization using World Health Organization (WHO) prescribing indicators, microbiological profile, and clinical outcomes in patients with chronic DFUs admitted to a tertiary care teaching hospital.
Methods: A 12-month prospective observational study was conducted in collaboration with the Departments of Pharmacology and General Surgery. Forty-two patients aged ≥30 years with chronic DFUs were enrolled after Institutional Ethics Committee approval and informed consent. Drug utilization was assessed using WHO/INRUD prescribing indicators. Wound healing was evaluated using the leg ulcer measurement tool (LUMT) at baseline, 1 week, and 4 weeks. Wound swabs were subjected to microbiological analysis, and data were analyzed using descriptive statistics.
Results: Most patients were males aged 41–60 years. Wound cultures were positive in 57.1% of cases, with Escherichia coli and Staphylococcus aureus being the predominant isolates. Polypharmacy was common (mean 6.8 drugs/prescription), although most medications were prescribed from the Essential Medicines List. β-lactams and nitroimidazoles were the most frequently prescribed antimicrobials. Mean LUMT scores decreased significantly over four weeks, indicating improved wound healing, and clinical cure was achieved in 78.6% of patients.
Conclusion: Rational pharmacotherapy guided by WHO prescribing indicators, culture-directed antimicrobial therapy, and standardized wound assessment using LUMT were associated with significant clinical improvement in patients with chronic diabetic foot ulcers.
References
Armstrong DG, Tan TW, Boulton AJ, Bus SA. Diabetic foot ulcers: a review. JAMA. 2023;330(1):62-75.
Parveen K, Hussain MA, Anwar S, Elagib HM, Kausar MA. Comprehensive review on diabetic foot ulcers and neuropathy: Treatment, prevention and management. World J Diabetes. 2025;16(3):100329.
Rastogi A, Kulkarni SA, Agarwal S, Akhtar M, Arsule S, Bhamre S, et al. Topical esmolol hydrochloride as a novel treatment modality for diabetic foot ulcers: a phase 3 randomized clinical trial. JAMA Network Open. 2023;6(5):2311509.
Ruke MG, Elavarasan SS, Devarajan A, Viswanathan V. Progress and challenges in diabetic foot care in South-East Asia and India-Current scenario. Diab Res Clin Pract. 2025;2:26.
Woodbury MG, Houghton PE, Campbell KE, Keast DH. Development, validity, reliability, responsiveness of the LUMT. Adv Skin Wound Care. 2004;17(4):190–8.
Khan F, Ullah A. Pharmacotherapy patterns of diabetic foot ulcer patients at a tertiary care hospital: a prospective study. Healthcraft Front. 2024;2(3):118-29.
Paramasivamsasanger K, Mariappan P, Govindasamy D, Karunakaran P, Ramesh R. A prospective observational study of drug prescription pattern of antibiotics in diabetic foot ulcer. Int J Basic Clin Pharmacol. 2020;9:1020-5.
Bhamre SD, Dikle AM. A study of microbial profile and drug resistance pattern in patients with diabetic foot at a tertiary health care center. MVP J Med Sci. 2020;7(1):9-15.
Varun S, Nair A, Moonnumacke D. Medication utilization practices in patients with diabetic foot ulcers in a tertiary care hospital. World J Pharm Res. 2022;11(11):1224-35.
Ashok P, Subrahmanian VT, Raj R, Babu RR, Ramshad TP, Kevin L. Prescription pattern analysis of type II diabetes mellitus inpatients and associated co-morbidities. J Drug Deliv Ther. 2020;10(3):1-6.
Paramasivamsasanger K, Mariappan P, Govindasamy D, Karunakaran P, Ramesh R. A prospective observational study of drug prescription pattern of antibiotics in diabetic foot ulcer. Int J Basic Clin Pharmacol. 2020;9:1020-5.
Downloads
Published
How to Cite
Issue
Section
